Wheaton Franciscan Healthcare- Reiman Cancer Center — Franklin, Wisconsin

Wheaton Franciscan Healthcare- Reiman Cancer Center is a clinical research site located in Franklin, Wisconsin, United States 53132.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Wheaton Franciscan Healthcare- Reiman Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Advanced Prostate Cancer, Prostatic Neoplasms, Metastatic Breast Cancer.

Sponsors: Dendreon, NewLink Genetics Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Franklin

Browse all research sites in Wisconsin · View every site in Franklin

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Wheaton Franciscan Healthcare- Reiman Cancer Center?

Wheaton Franciscan Healthcare- Reiman Cancer Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Wheaton Franciscan Healthcare- Reiman Cancer Center conducted?

Wheaton Franciscan Healthcare- Reiman Cancer Center has 2 clinical trials on record. Their work covers Advanced Prostate Cancer, Prostatic Neoplasms, Metastatic Breast Cancer.

Is Wheaton Franciscan Healthcare- Reiman Cancer Center accredited by Crixeo Clinical Trials?

Wheaton Franciscan Healthcare- Reiman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Wheaton Franciscan Healthcare- Reiman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.